Effects of oral exposure to zinc oxide nanoparticles on the peripheral organs of C57BL/6J mice

doi:10.12047/j.cjap.5859.2019.122

Abstract

Abstract: Objective: To investigate the effects of oral exposure of zinc oxide nanoparticles on multiple peripheral organs of C57BL/6J mice. Methods: Twenty male C57BL/6J mice were randomly divided into control group and experimental group, with 10 mice in each group. The experimental group was treated with continuous gavage administration of zinc oxide nanoparticle solution at a dose of 20 mg/kg body weight for 60 days, and the control group was given the corresponding amount of normal saline; the mice were weighed once a week. After the end of the exposure, blood samples was collected from the eyeballs, and the levels of blood sugar and lipids, liver and kidney function, and inflammatory factors such as platelet activating factor (PAF), interleukin-6 (IL-6) and tumor septicemia (TNF-α) were detected. Then, tissues sections of the heart, liver, spleen, lung, kidney and small intestine were prepared and their morphological changes were observed after hematoxylin-eosin staining. Results: There was no significant difference in body weight between control group and the experimental group. Compared with control group, the serum levels of albumin (ALB), albumin/globulin ratio(A/G), alkaline phosphatase (ALP) activity, aspartate aminotransferase/alanine aminotransferase ratio(AST/ALT), uric acid (UA) and blood urea in the experimental group were increased significantly (P＜0.05 or P＜0.01). There was no significant change in serum inflammatory factors. Pathological examination showed myocardial turbidity, mild inflammatory lesions (focal or small necrosis) in liver, decreased pigmentation in spleen, mild or moderate interstitial inflammation in lungs, and no obvious pathological changes in the kidneys or small intestine. Conclusion: Sixty days of oral exposure to nanometer zinc oxide did not cause inflammation in the blood system of C57BL / 6J mice, but it could induce mild pathological changes in the heart, liver, spleen and lungs, and lead to abnormal liver and kidney function.

Key words: zinc oxide nanoparticles, mouse, toxicity, organ

CLC Number:

R114

HAN Jie, TIAN Lei, LIU Zi-yi, FANG Zhen, XI Zhu-ge, LIU Xiao-hua. Effects of oral exposure to zinc oxide nanoparticles on the peripheral organs of C57BL/6J mice[J]. CJAP, 2019, 35(6): 555-558.

References

[1] John S, Marpu S, Li J, et al. Hybrid zinc oxide nanoparticles for biophotonics [J]. J Nanosci Nanotechnol, 2010, 10(3): 1707-1712.
[2] Oberdorster G, Oberdorster E, Oberdorster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles [J]. Environ Health Perspect, 2005, 113(7): 823-839.
[3] Esmaeillou M, Moharamnejad M, Hsankhani R, et al. Toxicity of ZnO nanoparticles in healthy adult mice [J]. Environ Toxicol Pharmacol, 2013, 35(1): 67-71.
[4] Hong TK, Tripathy N, Son HJ, et al. A comprehensive in vitro and in vivo study of ZnO nanoparticles toxicity[J]. J Mater Chem B, 2013, 1(23): 2985-2992.
[5] Kimc CS, Nguyen HD, IgnacioRM, et al. Immunotoxicity of zinc oxide nanoparticles with different size and electrostatic charge[J]. Int J Nanomedicine, 2014, 9(2): 195-205.
[6] Wang J, Zhou G, Chen C, et al. Acute toxicity and biodistribution of different sized titanium dioxide particles in mice after oral administration [J]. Toxicol Lett, 2007, 168(2): 176-185.
[7] Lin W, Xu Y, Huang CC, et al. Toxicity of nano- and micro-sized ZnO particles in human lung epithelial cells[J]. J Nanopart Res, 2009, 11: 25-39.
[8] Yuan JH, Chen Y, Zha HX, et al. Determination, characterization and cytotoxicity on HELF cells of ZnO nanoparticles [J]. Colloids Surf B Biointerfaces, 2010, 76(1): 145-150.
[9] Huang CC, Aronstam RS, Chen DR, et al. Oxidative stress, calcium homeostasis, and altered gene expression in human lung epithelial cells exposed to ZnO nanoparticles [J]. Toxicol In Vitro, 2010, 24(1): 45-55.
[10]李慧民, 孔涛, 杨自军, 等. 暴露纳米氧化锌对雄性小鼠糖、脂代谢及组织学的影响[J]. 中国兽医学报, 2017, 37(3): 530-534.
[11]Kim YR, Park J, Lee EJ, et al. Toxicity of 100 nm zinc oxide nanoparticles: a report of 90-day repeated oral administration in Sprague Dawleyrats[J]. Int J Nanomedicine, 2014, 9(2): 109-126.
[12]Ansar S, Abudawood M, Hamed SS, et al. Exposure to zinc oxide nanoparticles induces neurotoxicity and proinflammatory response: Amelioration by hesperidin[J]. Biol Trace Elem Res, 2017, 175: 360-366.
[13]Ben-Slama I, Amara S, Mrad I, et al. Sub-acute oral toxicity of zinc oxide nanoparticles in male rats[J]. J Nanomed Nanotechnol, 2015, 6(3): 100284-100289.
[14]Abbasalipourkabir R, Moradi H, Zarei, S. Toxicity of zinc oxide nanoparticles on adult male Wistar rats[J]. Food Chem Toxicol, 2015, 84: 154-160.
[15]Almansour MI, Alferah MA, Shraideh ZA. Zinc oxide nanoparticles hepatotoxicity: Histological and histochemicalstudy[J]. Environ Toxicol Pharmacol, 2017, 51: 124-132.
[16]Kong T, Zhang S H, Zhang C, et al. Long-term effects of unmodified 50 nm ZnO in mice [J]. Biol Trace Elem Res, 2018, 189(2): 478-489.
[17]Wang B, Feng W, Wang T, et al. Acute toxicity of nano- and micro-scale zinc powder in healthy adult mice[J]. Toxicol Lett, 2006, 161: 115-123.
[18]Wang B, Feng W, Wang M, et al. Acute toxicological impact of nano- and submicro-scaled zinc oxide powder on healthy adult mice [J]. J Nanpart Res, 2007, 10(2): 263-276.
[19]Chuang HC, Juan HT, Chang CN, et al. Cardiopulmonary toxicity of pulmonary exposure to occupationally relevant zinc oxide nanoparticles [J]. Nanotoxicology, 2014, 8(6): 593-604.
[20]吴诚, 文利新, 袁慧, 等. 纳米氧化锌对小鼠的毒性试验[J]. 粮食与饲料工业, 2008, 5: 38-39.